CEA |
|
|
The abbreviation CEA may refer to: California Earthquake Authority Cambridge Electron Accelerator Carcinoembryonic antigen, a tumor marker for colorectal cancer. Carotid endarterectomy, a surgical procedure involving the carotid artery Centro de Educación ArtÃstica, an arts institute in Mexico City owned by Televisa Collective employment agreement (in collective bargaining) College of Engineering Adoor, An engineering college at Adoor, Kerala affiliated to CUSAT Collie eye anomaly Consume ...
Wikipedia - [full article]
CEA Clinical Trials
- Vaccine Therapy and Radiation to Liver Metastasis in Patients with CEA-Positive Solid Tumors
ClinicalTrials.gov Identifier: NCT00081848 - Recruiting
Liver Neoplasms
- Vaccine and Chemotherapy for Previously Untreated Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00048893 - Recruiting
Breast Neoplasms; Metastases, Neoplasm
- A Phase I/II Study With CEA(6D) VRP Vaccine in Patients With Advanced or Metastatic CEA-Expressing Malignancies
ClinicalTrials.gov Identifier: NCT00529984 - Recruiting
Colorectal Cancer; Breast Cancer; Lung Cancer; Pancreatic Cancer
- Vaccine Therapy, GM-CSF, and Interferon Alfa-2b in Treating Patients With Locally Advanced or Metastatic Cancer That Expresses Carcinoembryonic Antigen (CEA)
ClinicalTrials.gov Identifier: NCT00217373 - Recruiting
unspecified adult solid tumor, protocol specific
- Vaccine and Combined Chemotherapy/Radiotherapy to Treat Inoperable Lung Cancer
ClinicalTrials.gov Identifier: NCT00088725 - Recruiting
Carcinoma; Non-Small Cell Lung
- Vaccine Therapy With or Without Sargramostim in Treating Patients With Cancer
ClinicalTrials.gov Identifier: NCT00009958 - Active, not recruiting
unspecified adult solid tumor, protocol specific
- Immunotherapy for Colorectal Cancers Using CEA-Pulsed Dendritic Cells and Subsequent IL-2 Treatment
ClinicalTrials.gov Identifier: NCT00154713 - Recruiting
Colorectal Cancer
- Vaccines to Treat Metastatic Carcinoma
ClinicalTrials.gov Identifier: NCT00088413 - Recruiting
Adenocarcinoma
- V930 First in Man (FIM) Study
ClinicalTrials.gov Identifier: NCT00250419 - Active, not recruiting
Cancers Expressing HER-2 and/or CEA
- Vaccine Therapy and Sargramostim With or Without Docetaxel in Treating Patients With Metastatic Lung Cancer or Metastatic Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00088933 - Active, not recruiting
Colon Cancer; Non-small cell lung cancer; Rectal Cancer; Small Cell Lung Cancer
- Vaccine Therapy in Treating Patients With Liver Metastases From Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00103142 - Recruiting
Colon Cancer; liver metastases; Rectal Cancer
- Docetaxel With or Without Vaccine Therapy and GM-CSF in Treating Patients With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00217750 - Recruiting
Male Breast Cancer; recurrent breast cancer; stage IV breast cancer
- Study of Early Versus Delayed Carotid Endarterectomy (CEA) for Small to Medium-Sized Ischemic Stroke Caused by High-Grade Carotid Stenosis
ClinicalTrials.gov Identifier: NCT00315562 - Active, not recruiting
Stroke; Carotid Stenosis
- Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced Tumors
ClinicalTrials.gov Identifier: NCT00003125 - Active, not recruiting
stage IIIB non-small cell lung cancer; stage III pancreatic cancer; stage IV breast cancer; stage IIIA non-small cell lung cancer; ...
- Safety Study of 2nd Generation Anti-CEA Designer T Cells to Treat Gastric Cancer
ClinicalTrials.gov Identifier: NCT00429078 - Recruiting
Gastric Cancer
- Phase II Study of the Role of Anti-CEA Antibody Immunoscintigraphy & Positron Emission Tomography in the Localization of Recurrent Colorectal Carcinoma in Patients with Rising Serum CEA Levels in the Absence of Imageable Disease by Conventional Modali
ClinicalTrials.gov Identifier: NCT00001568 - Completed
Colorectal Neoplasm
- Sequential Vaccinations in Combination with Standard Adjuvant Chemotherapy in High-Risk Breast Cancer Patients Following Surgical Treatment
ClinicalTrials.gov Identifier: NCT00047398 - Completed
Breast Neoplasms
- Vaccine Therapy and Sargramostim in Treating Patients With Metastatic Cancer
ClinicalTrials.gov Identifier: NCT00091000 - Recruiting
stage IV colon cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer; unspecified adult solid tumor, protocol specific
- PROTECTed Carotid Artery Stenting in Subjects at High Risk for Carotid Endarterectomy (CEA)
ClinicalTrials.gov Identifier: NCT00402740 - Recruiting
Carotid Artery Disease
- Assessment of Frequency of Surveillance After Curative Resection in Patients with Stage II and III Colorectal Cancer.
ClinicalTrials.gov Identifier: NCT00225641 - Recruiting
Colorectal Cancer
- Gene Therapy in Treating Patients With Cancer
ClinicalTrials.gov Identifier: NCT00004178 - Active, not recruiting
Lung Cancer; Pancreatic Cancer; Gastric Cancer; Salivary Gland Cancer; Renal Cell Cancer; Endometrial Cancer; Esophageal Cancer; Head and Neck Cancer; ...
- Vaccine Therapy and Chemotherapy With or Without Tetanus Toxoid Compared With Chemotherapy Alone in Treating Patients With Metastatic Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00027833 - Active, not recruiting
stage IV colon cancer; Stage IV rectal cancer; adenocarcinoma of the colon; adenocarcinoma of the rectum
- Denileukin Diftitox Followed by Vaccine Therapy in Treating Patients With Metastatic Cancer
ClinicalTrials.gov Identifier: NCT00128622 - Recruiting
adult solid tumor; Breast Cancer; Colorectal Cancer; Lung Cancer; Male Breast Cancer; Pancreatic Cancer
- Vaccine Therapy, Chemotherapy, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed With Surgery
ClinicalTrials.gov Identifier: NCT00091039 - Completed
stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer
- CAPITAL: Carotid Artery Plaque Intravascular Ultrasound Evaluation
ClinicalTrials.gov Identifier: NCT00271076 - Completed
Carotid Artery Disease
- Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer
ClinicalTrials.gov Identifier: NCT00027534 - Completed
Breast Cancer; Endocrine Cancer; female reproductive cancer; Gastrointestinal Cancer; Head and Neck Cancer
- Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer
ClinicalTrials.gov Identifier: NCT00028496 - Completed
Breast Cancer; Endocrine Cancer; female reproductive cancer; Gastrointestinal Cancer; Head and Neck Cancer

Not Signed In -


